John Scott Cameron

Person

Belmont, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-...
- Patent number 11,078,191
- Issue date Aug 3, 2021
- Novartis AG
- Sanela Bilic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combined use of anti PD-1 and anti M-CSF antibodies in the treatmen...
- Patent number 11,001,628
- Issue date May 11, 2021
- Novartis AG
- Marie-Louise Fjaellskog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine for use in the tr...
- Patent number 10,561,653
- Issue date Feb 18, 2020
- Novartis AG
- Sanela Bilic
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biomarkers for IAP inhibitor therapy
- Patent number 9,353,419
- Issue date May 31, 2016
- Novartis AG
- Dale Porter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
DOSING REGIMEN AND PHARMACEUTICAL COMBINATION COMPRISING 3-(1-OXOIS...
- Publication number 20240245670
- Publication date Jul 25, 2024
- Novartis AG
- Simone BONAZZI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIOLABELLED ALPHA-V BETA-3 AND/OR ALPHA-V BETA-5 INTEGRINS ANTAGO...
- Publication number 20240050597
- Publication date Feb 15, 2024
- ADVANCED ACCELERATOR APPLICATIONS INTERNATIONAL S.A.
- Valeria MUZIO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF C-MET INHIBITOR WITH ANTIBODY MOLECULE TO PD-1 AND U...
- Publication number 20210121563
- Publication date Apr 29, 2021
- Novartis AG
- Sanela BILIC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES
- Publication number 20200277378
- Publication date Sep 3, 2020
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF C-MET INHIBITOR WITH ANTIBODY MOLECULE TO PD-1 AND U...
- Publication number 20200261573
- Publication date Aug 20, 2020
- Sanela Bilic
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1-(4-AMINO-5-BROMO-6-(1H-PYRAZOL-1-YL)PYRIMIDIN-2-YL)-1H-PYRAZOL-4-...
- Publication number 20190359600
- Publication date Nov 28, 2019
- Novartis AG
- Sanela BILIC
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPIES OF CHIMERIC ANTIGEN RECEPTORS AND PD-1 INHIBI...
- Publication number 20190151365
- Publication date May 23, 2019
- Novartis AG
- Oezlem Anak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
- Publication number 20180371093
- Publication date Dec 27, 2018
- Novartis AG
- Sanela Bilic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5-BROMO-2,6-DI-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE FOR USE IN THE TR...
- Publication number 20180228802
- Publication date Aug 16, 2018
- Novartis AG
- Sanela BILIC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINED USE OF ANTI PD-1 AND ANTI M-CSF ANTIBODIES IN THE TREATMEN...
- Publication number 20180222973
- Publication date Aug 9, 2018
- Novartis AG
- Marie-Louise Fjaellskog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination of PD-1 antagonist with an EGFR inhibitor
- Publication number 20180177872
- Publication date Jun 28, 2018
- Yong Jia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKERS FOR IAP INHIBITOR THERAPY
- Publication number 20150105434
- Publication date Apr 16, 2015
- Dale Porter
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

John Scott Cameron

Person

Patents Grantslast 30 patents

1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-...

Combined use of anti PD-1 and anti M-CSF antibodies in the treatmen...

5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine for use in the tr...

Biomarkers for IAP inhibitor therapy

Patents Applicationslast 30 patents

DOSING REGIMEN AND PHARMACEUTICAL COMBINATION COMPRISING 3-(1-OXOIS...

RADIOLABELLED ALPHA-V BETA-3 AND/OR ALPHA-V BETA-5 INTEGRINS ANTAGO...

COMBINATION OF C-MET INHIBITOR WITH ANTIBODY MOLECULE TO PD-1 AND U...

COMBINATION THERAPIES

COMBINATION OF C-MET INHIBITOR WITH ANTIBODY MOLECULE TO PD-1 AND U...

1-(4-AMINO-5-BROMO-6-(1H-PYRAZOL-1-YL)PYRIMIDIN-2-YL)-1H-PYRAZOL-4-...

COMBINATION THERAPIES OF CHIMERIC ANTIGEN RECEPTORS AND PD-1 INHIBI...

ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

5-BROMO-2,6-DI-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE FOR USE IN THE TR...

COMBINED USE OF ANTI PD-1 AND ANTI M-CSF ANTIBODIES IN THE TREATMEN...

Combination of PD-1 antagonist with an EGFR inhibitor

BIOMARKERS FOR IAP INHIBITOR THERAPY